Atea Pharmaceuticals, Inc.
Clinical trials sponsored by Atea Pharmaceuticals, Inc., explained in plain language.
-
New hepatitis c drug combo goes Head-to-Head with standard treatment
Disease control Recruiting nowThis study is testing whether a new two-drug combination (BEM/RZR) works as well as or better than the current standard treatment (SOF/VEL) for chronic hepatitis C. The trial will involve 880 adults who have never received this type of antiviral treatment before. Researchers will…
Phase: PHASE3 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Early safety check: how do failing organs handle new drugs?
Knowledge-focused Recruiting nowThis early-stage study aims to understand how a single dose of a new antiviral drug combination is processed by the body in people with severe liver or kidney impairment. It will compare the drug's levels and safety in these participants to a matched group of healthy volunteers. …
Phase: PHASE1 • Sponsor: Atea Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC